Accessibility Menu

What Is an Intention-to-Treat Analysis?

By Kristi WaterworthUpdated Feb 26, 2025 at 3:22 PM

Key Points

  • Intention-to-treat analysis keeps all trial data, showing true drug effects, even with dropouts.
  • It contrasts with per-protocol analysis, where dropout data is excluded, possibly skewing results.
  • Understanding both analyses helps investors assess drug performance accurately before investing.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.